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Abstract
Background: The enzyme cytosolic phospholipase A2 alpha (cPLA2a) has been implicated in the progression of
cerebral injury following ischemia and reperfusion. Previous studies in rodents suggest that cPLA2a enhances
delayed injury extension and disruption of the blood brain barrier many hours after reperfusion. In this study we
investigated the role of cPLA2a in early ischemic cerebral injury.
Methods: Middle cerebral artery occlusion (MCAO) was performed on cPLA2a
+/+ and cPLA2a
-/- mice for 2 hours
followed by 0, 2, or 6 hours of reperfusion. The levels of cPLA2a, cyclooxygenase-2, neuronal morphology and
reactive oxygen species in the ischemic and contralateral hemispheres were evaluated by light and fluorescent
microscopy. PGE2 content was compared between genotypes and hemispheres after MCAO and MCAO and
6 hours reperfusion. Regional cerebral blood flow was measured during MCAO and phosphorylation of relevant
MAPKs in brain protein homogenates was measured by Western analysis after 6 hours of reperfusion.
Results: Neuronal cPLA2a protein increased by 2-fold immediately after MCAO and returned to pre-MCAO levels
after 2 hours reperfusion. Neuronal cyclooxygenase-2 induction and PGE2 concentration were greater in cPLA2a
+/+
compared to cPLA2a
-/- ischemic cortex. Neuronal swelling in ischemic regions was significantly greater in the
cPLA2a
+/+ than in cPLA2a
-/- brains (+/+: 2.2 ± 0.3 fold vs. -/-: 1.7 ± 0.4 fold increase; P < 0.01). The increase in
reactive oxygen species following 2 hours of ischemia was also significantly greater in the cPLA2a
+/+ ischemic core
than in cPLA2a
-/- (+/+: 7.12 ± 1.2 fold vs. -/-: 3.1 ± 1.4 fold; P < 0.01). After 6 hours of reperfusion ischemic cortex
of cPLA2a
+/+, but not cPLA2a
-/-, had disruption of neuron morphology and decreased PGE2 content.
Phosphorylation of the MAPKs-p38, ERK 1/2, and MEK 1/2-was significantly greater in cPLA2a
+/+ than in cPLA2a
-/-
ischemic cortex 6 hours after reperfusion.
Conclusions: These results indicate that cPLA2a modulates the earliest molecular and injury responses after
cerebral ischemia and have implications for the potential clinical use of cPLA2a inhibitors.
Background
Phospholipase A2 (PLA2) enzymes hydrolyze free fatty
acids from the second position (sn-2) of membrane
glycerophospholipids and augment neurologic injuries of
oxidative stress (reviewed by Muralikrishna [1]). The
cytosolic phospholipase A2a (cPLA2a,a l s ok n o w na s
PLA2 group IVA) is a member of the larger PLA2 super-
family and has unique properties that suggest it may
regulate formation of eicosanoids in cell-signalling path-
ways. cPLA2a resides in the cytosol but translocates to
intracellular membranes in response to physiologic Ca
2+
changes [2]. cPLA2a has a strong preference for hydro-
lysis of arachidonic acid (AA); is a major source of regu-
lated, intracellular AA [3]; and is regulated by the
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amino acids [4]. We previously demonstrated that
cPLA2a is a key effector of neurologic injury following
cerebral ischemia and reperfusion (I/R) by showing that
cPLA2a
-/- mice have significantly less stroke injury than
do wild-type littermate (+/+) mice after transient regio-
nal cerebral ischemia [5]. The presence of cPLA2a in
neurons [6] and its biochemical properties suggest that
it could play a major regulatory role in neurologic sig-
nalling in ischemia and other neurologic diseases [7,8].
cPLA2a also has a role in the regulation of the down-
stream enzymes that metabolize AA to the eicosanoids
[9,10], which are important mediators of acute and
chronic neurologic injury in stroke [11]. The role of
COX-2 is particularly well-explored in cerebral I/R and
is tightly correlated with cPLA2a. Inhibition or gene
deletion of COX-2 decreases while COX-2 overexpres-
sion enhances neuronal injury following MCAO [12-14].
In mice cPLA2a expression appears to be necessary to
maintain normal basal and induced expression of COX-
2i nt h eb r a i n[ 1 0 , 1 5 ] .c P L A 2a-derived arachidonic acid
is also tightly coupled to the 5-lipoxygenase enzyme [16]
and in the gerbil model of global cerebral ischemia 15
minutes of reperfusion caused translocation of 5-LO to
the neuron membranes and resulted in increased levels
of leukotriene C4 [17]. cPLA2a amplifies the increase in
permeability of the blood-brain barrier after transient
ischemia [7], and eicosanoids contribute to the subse-
quent inflammatory responses [18]. The eicosanoids,
particularly prostaglandins (PGs), and AA itself may also
contribute directly to the early excitotoxicity that pre-
cedes neuroinflammation [19-23]. Our lab and others
found that cPLA2a can have a direct and early effect on
excitotoxicity in vitro [19,24,25].
Here, we examined the effect of transient regional cer-
ebral I/R on cPLA2a expression and, in turn, the effect
of cPLA2a on cyclooxygenase (COX)-2 expression,
PGE2 levels and reactive oxygen species (ROS) early in
the cell-death cascade. We applied transient middle cer-
ebral artery (MCA) occlusion (MCAO) to cPLA2a
+/+
and cPLA2a
-/- mice and investigated the effect of
cPLA2a on early pathways of neurologic injury at 0, 2,
and 6 hours of reperfusion. We then correlated cPLA2a
expression with ROS generation and the phosphoryla-
tion of relevant MAPKs. Our results indicate that
cPLA2a contributes to I/R injury immediately after
ischemia.
Methods
Materials
Unless otherwise stated, all compounds were purchased
from Sigma-Aldrich Company (St. Louis, MO). For
immunomicroscopy anti-cPLA2a (P505) was purchased
from Abcam Inc. (Cambridge, MA). Rabbit anti-cPLA2a
(N-216) and anti-b-actin antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). Alexa Fluor 488
and 568 donkey anti-rabbit IgG and NeuroTrace 435/
455 Nissl Stain (NT) were purchased from Invitrogen
Corporation (Carlsbad, CA).
Animal Care
All experiments were conducted in accordance with the
guidelines of the National Institutes of Health and
approved by the Johns Hopkins University Institutional
Animal Care and Use Committee. cPLA2a
+/- mice were
a gift from Takao Shimizu (Tokyo University) and were
supplied by Jim Clark (Wyeth Pharmaceutical, Cam-
bridge, MA). Mice were housed in a facility with 12-
hour diurnal light cycle with free access to food and
water. All experimental mice were produced by mating
male and female cPLA2a
+/- mice that were produced
and maintained in the C57BL/6J strain.
Focal Cerebral Ischemia
Transient focal ischemia was induced by MCAO in 10-
14-week-old age-matched cPLA2a
-/- and cPLA2a
+/+ lit-
termates between 20-28 g. Anesthesia was by sponta-
neous ventilation of isoflurane in 30% O2.A
thermostatically controlled warming pad and infrared
light were used to maintain the rectal temperature at
37.5 ± 0.5°C during all phases of the surgery. Left-sided
MCAO and sham surgery were performed as previously
described [5]. After 2 hours of MCAO, the mice were
re-anesthetized, the occlusive suture was removed, and
the mice were placed in a temperature-controlled
environment.
In experiments to measure oxidative stress, 10 mg/kg
dihydroethidium (HE) was injected into the jugular vein
at the beginning of MCAO. The mice underwent 2-hour
MCAO with continuous monitoring of cerebral blood
flow (CBF) by laser-Doppler flowmetry, and at 0 or 2
hours of reperfusion, the mice were sacrificed, perfusion
fixed, and the brains harvested.
Regional CBF Assessment
Regional CBF (rCBF) was measured at 60 minutes of
ischemia in mice of each genotype and strain, by using
[
14C]-iodoantipyrine ([
14C]-IAP) autoradiography, as
previously described [26]. MCAO was carried out as
described above, with additional placement of femoral
arterial and venous catheters. At 60 minutes of MCAO,
arterial blood pressure, pH, PaCO2, and PaO2 were mea-
sured, and 4 μCi of [
14C]-IAP was infused intravenously.
Coronal brain sections (20 μm) cut on a cryostat were
exposed to BioMax film (Kodak, Rochester, NY) for
10 days with [
14C] standards. From each mouse, we digi-
tized three autoradiographic images from five positions
corresponding to coronal sections at +2, +1, 0, -1, and
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anterior cerebral artery (ACA) and MCA territories
were outlined in the ipsilateral and contralateral cortex,
and signal intensity was determined (ImageJ version
1.36, NIH, Bethesda, MD). rCBF was calculated as pre-
viously described [26], and measurements in the three
consecutive coronal slices were averaged at each posi-
tion to yield values of absolute rCBF in each region.
Fluorescence Microscopy and Quantitative Digital
Image Analysis
Following terminal anesthesia, mice were perfused with
3 × weight/volume of normal saline, followed by 4%
paraformaldehyde in PBS, and post-fixed in 4% parafor-
maldehyde and 15% sucrose. For immunofluorescence,
30 μm coronal sections were blocked and quenched
with 0.5% H2O2 in 0.3% normal donkey serum in PBS
and incubated with primary antibody overnight at 4°C.
The samples were incubated with secondary antibody
followed by DAB treatment. Slides were counter-stained
with fluorescent Nissl reagent to enable identification of
intact neurons by presence of the Nissl substance [27].
Coronal brain sections were examined by confocal
microscope LSM510 META (Zeiss, Thornwood, NY). NT,
Alexa Fluor 488, and Alexa Fluor 568 were excited with a
405 nm diode laser, a 488 nm Argon laser, and a 561 nm
helium-neon laser, respectively. Emission was detected
through 420-480-nm, 505-530-nm, and 565-595-nm
band-pass filters, respectively. HE was visualized by excita-
tion at 561 nm and emission at 610 nm. An investigator
blinded to genotype and hemisphere used Image J soft-
ware to measure total cPLA2a fluorescence in low magni-
fication (10×) images obtained from representative brain
sections of cPLA2a
+/+ and cPLA2a
-/- mice.
For high resolution analysis, two representative images
in the cortical subfield of interest were acquired from
each of three brain sections per mouse, and two z-
planes of ~2 μm optical thickness separated by 8 μm
were sampled. Fluorescence threshold levels were set to
allow for recognition of individual neurons in slices
without signal saturation and were constant for analysis
of all slices. The anatomical regions corresponding to
the ischemic core and penumbra were identified in
fluorescent Nissl-stained sections. Fluorescence above
the threshold was measured in 120-130 neurons for
each mouse in non-overlapping, randomly chosen
regions in photomicrographs obtained using 100× mag-
nification. Total pixel area was normalized to the total
area analyzed and number of neurons and expressed in
arbitrary units.
Immunoblotting
For Western analysis, primary antibodies included COX-
2 (1:1000, Cayman Chemical Co. Ann Arbor, MI),
cPLA2a (1:500), phospho-cPLA2a (1:500), ERK1/2 and
phospho-ERK1/2 (1:1000), MEK1/2 and phospho-
MEK1/2 (1:1000), p38 MAPK and phospho-p38 MAPK
(1:1000) (all from Cell Signalling Technology, Inc. Dan-
vers, MA). Protein samples were separated by electro-
phoresis and transferred to PVDF membranes.
Immunocomplexes were visualized by enhanced chemi-
luminescence detection (Amersham Life Science).
Subcellular fractions were prepared from brain tissue
homogenized by Dounce (20 strokes) in 10× v/w of ice-
cold lysis buffer (2 mM EGTA in PBS with protease
inhibitor), and 1/10 volume of benzonase solution (1:50
dilution). The samples were gently shaken on ice for 20
minutes and centrifuged at 800 × g for 10 minutes at
4°C. Supernatant volumes of 100 μl were centrifuged at
100,000 × g for 45 min at 4°C. The supernatants con-
tained the cytosolic fraction. The pelleted nuclear frac-
tion was resuspended in 0.7 w/v CHAPS lysis buffer,
sonicated for 10 seconds and incubated on ice for
30 minutes. Protein concentrations were measured by
the modified Bradford assay. Cell lysate proteins (25 μg
per sample) were electrophoretically resolved on 4-15%
polyacrylamide Tris-HCl gradient gels (BioRad, Her-
cules, CA) and transferred to PVDF membranes. Each
membrane was probed and stripped sequentially for
phospho-cPLA2a, cPLA2a,a n db-actin. For routine
immunodetection of proteins cortical hemispheres were
homogenized in 5 × v/w buffer, and 10 μgo fc r u d e
homogenate was used for SDS-PAGE.
Prostaglandin E2 (PGE2) Enzyme Immunoassay
Cortical tissue was weighed and homogenized by polytron
in 10 μl/mg wet tissue of ice-cold PBS with 10 μg/ml indo-
methacin and incubated on ice for 10 min. The homoge-
nate solution was brought to 40% volume aqueous ethanol
and acidified with glacial acetic acid to pH 3.0, incubated
for 5 min at room temperature, and centrifuged at 2,500 ×
g for 10 min. The supernatant was applied to a condi-
tioned Oasis HLB column (Waters Corp., Milford, MA),
washed with 0.03% formic acid, followed by 15% aqueous
ethanol/0.03% formic acid followed by petroleum ether.
PGs were eluted with ethyl acetate and evaporated to dry-
ness under nitrogen. The eluant was dissolved in 300 μL
assay buffer, and PGE2 concentration was determined by
ELISA according to the manufacturer’s instructions (Assay
Designs, Ann Arbor, MI.). For each extraction and ELISA
the results were normalized within the group to account
for variation in the efficiency of lipid extraction.
Statistical Analysis
Assays that required multiple samples from a single
mouse were analyzed by averaging the intra-mouse sam-
ples and then performing statistical annalysis between
individuals. For studies in which multiple time points
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lysis was performed by repeated measures ANOVA and
post-hoc comparison between genotypes was made with
the Newman-Keuls test. Comparison of relative PGE2
concentrations following MCAO between genotypes and
hemispheres was conducted with 2-way ANOVA fol-
lowed by Bonferroni testing between the genotypes
using GraphPad Prism version 5.03 (GraphPad Software,
San Diego California). Densitometry analysis was
by paired t-tests. For all procedures; P < 0.05 was con-
sidered statistically significant. Data are expressed as
mean ± s.d.
Results
To examine the effect of cPLA2a expression on the cas-
cade of molecular and cellular events in vivo following
cerebral I/R, we subjected cPLA2a
+/+ and cPLA2a
-/-
mice to 2 hours of MCAO followed by no (0), 2, or 6
hours of reperfusion and examined the expression of
cPLA2a using immunofluorescence coupled with Nissl
staining. We observed a substantial increase in the level
of cPLA2a staining in the cPLA2a
+/+ mice after 2 hours
of MCAO and no reperfusion. The averaged cPLA2a
fluorescence intensity in cPLA2a
+/+ ischemic hemi-
spheres was 1.9 fold greater than that in contralateral
hemispheres (P < 0.01). As expected, the nonspecific
staining in cPLA2a
-/- hemispheres was barely detectable
and was not altered by ischemia. We then used high
resolution imaging to characterize the cellular expres-
sion patterns of cPLA2a that follow MCAO in the
ischemic core and penumbra regions. We observed a
very low level of cPLA2a immunofluorescence in
cPLA2a
+/+ mice after sham surgery (Figure 1A a-d).
After 2 hours of ischemia, the immunofluorescence was
markedly increased in the neurons and non-neuronal
cells of the ischemic hemisphere (Figure 1A e-f) but was
unchanged in the contralateral hemisphere (Figure 1A
g-h). However, after 2 hours of reperfusion, cPLA2a was
substantially lower in the neurons of the penumbra (Fig-
ure 1A i) and almost absent in the neurons of the
ischemic zone (Figure 1A j). Nissl staining suggests loss
of neurons in the ischemic core after 2 hours of reperfu-
sion (Figure 1A j). Six hours after reperfusion, cPLA2a
immunofluorescence could not be distinguished from
that of sham-operated mice (data not shown). The
cPLA2a
-/- mice had minimal, nonspecific background
staining (Figure 1A m-x). Phosphorylated cPLA2a also
showed a marked increase in cPLA2a
+/+ brain after
2 hours of ischemia and then decreased along a time
course similar to that of unphosphorylated cPLA2a
(Figure 1B).
To validate the results of the immunofluorescence
experiments, cPLA2a
+/+ mice were subjected to 2-hour
MCAO and no reperfusion, or sham operation.
Following euthanasia the ipsilateral and contralateral
cortices were harvested for protein extraction. We per-
formed a subcellular fractionation on the cortical pro-
teins and subjected these to Western blot analysis using
anti-cPLA2a and anti-phospho-cPLA2a antibodies. The
anti-cPLA2a antibody recognizes both the phosphory-
lated and unphosphorylated forms of cPLA2a and this
leads to the formation of a doublet on immunoblot. The
upper band of this doublet is the phospho-cPLA2a form
and this is confirmed with the anti-phospho-cPLA2a
antibody. Consistent with the immunofluorescence find-
ings, 2 hours of ischemia increased total and phospho-
cPLA2a in the ipsilateral cytosolic fraction as compared
to the contralateral (non-ischemic) cytosolic fraction
(Figure 2). Expression levels of total and phospho-
cPLA2a in the membrane fraction did not differ
between the ipsilateral and contralateral hemispheres.
This indicates that cPLA2a is not associated with cellu-
lar membranes following 2 hours of MCAO.
Nissl staining illustrated that I/R caused much greater
disruption of cortical pyramidal neuron morphology in
cPLA2a
+/+ mice than in cPLA2a
-/- mice. Neurons in the
core and penumbra regions were enlarged immediately
after 2-hour ischemia (0 hours of reperfusion) and after
2 hours of reperfusion (Figure 3A and Table 1). The
expression of cPLA2a was associated with greater neu-
ronal swelling at both time points. After 6 hours of
reperfusion, neuronal structure in the cPLA2a
+/+ ipsilat-
eral hemisphere was almost completely disrupted with a
dramatic reduction in the number of neurons
(Figure 3B, a). The structure and number of neurons in
cPLA2a
-/- mouse brains, however, remained intact
(Figure 3B, c).
cPLA2a regulates COX-2 expression in the brain
[10,15] and nonspecific PLA2 blockade prevents COX-2
induction after transient focal ischemia [28]. We exam-
ined the effect of cPLA2a deletion on COX-2 expression
after I/R. In the ipsilateral cortices of cPLA2a
+/+ mice,
COX-2 immunofluorescence was substantially greater
than that in sham-operated controls immediately after
ischemia (Figure 4A a-b compared to i-j) and increased
further 2 hours after reperfusion (Figure 4A e-f). In con-
trast, COX-2 was not elevated in the ipsilateral cortex of
cPLA2a
-/- mice (Figure 4A m-n) and was only slightly
increased after 2 hours of reperfusion (Figure 4A q-r).
PGE2 is produced by the coordinated enzymatic activ-
ities of COX and the PGE synthases upon AA. Previous
studies have demonstrated that PGE2 levels are elevated
following MCAO in the rat hippocampus [29]. We com-
pared the levels of PGE2 in the cortex of cPLA2a
+/+ and
-/- mice immediately following 2 hours of ischemia and
no reperfusion (Figure 5A) or after 6 hours of reperfu-
sion (Figure 5B). In agreement with previous results
there was no significant difference between basal PGE2
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+/+ neurons. A: Immunofluorescence of cPLA2a (green) and fluorescent Nissl dye (blue)
in brain slices from cPLA2a
+/+ and cPLA2a
-/- mice after sham surgery, 2-hour MCAO, or 2-hour MCAO and 2-hour reperfusion. Images from the
ischemic core and penumbra regions from the ipsilateral and contralateral hemispheres of each genotype are shown. B: Immunofluorescence of
Ser505-phosphorylated cPLA2a (green) in cPLA2a
+/+ mice subjected to sham surgery (a-d), 2 hours of MCAO (e-h) or 2 hours of MCAO and 2
hours of reperfusion (i-l). Fluorescent Nissl staining of neurons is in blue. Representative images, n = 3 mice of each genotype. Ipsi, ipsilateral;
Contra, contralateral.
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+/+ and -/- cortex [10]. However 2
hours of MCAO caused a significant increase in the
PGE2 concentration of both the contralateral and ipsilat-
eral cPLA2a
+/+ cortices. In contrast the levels of PGE2
were not changed by ischemia in the cPLA2a
-/- cortex.
After 6 hours of reperfusion the concentration of PGE2
in ischemic cPLA2a
+/+ cortex was significantly lower
than in cPLA2a
-/- cortex or in the contralateral cortex
of either genotype (Figure 5B).
We also evaluated the role of cPLA2a expression in
the generation of ROS using the fluorescent probe HE.
The increase in ROS in the ischemic hemisphere of
cPLA2a
+/+ mice was significantly greater than in the
cPLA2a
-/- mice following ischemia without reperfusion
(Figure 6A, 0 h) (+/+: 7.12 ± 1.2 fold increase vs. -/-:
3.10 ± 1.4 fold increase, P < 0.01) and also 2 hours after
ischemia (Figure 6A and Table 2). Levels of ROS in the
contralateral hemispheres were not different from levels
in sham-operated mice.
To determine if differences in ROS levels between
cPLA2a
+/+ and cPLA2a
-/- mice resulted from differences
in the vascular responses during ischemia, rCBF was
measured by the technique of [
14C]-IAP injection. The
cortical regions corresponding to the ACA and MCA
were demarcated in coronal brain sections. MCAO
caused a significant reduction of blood flow in both the
ACA and MCA territories, relative to the contralateral
sides in each genotype (Figure 6B). CBF was slightly
lower in the ipsilateral ACA territory in the anterior
region of the cPLA2a
-/- brain than in the corresponding
region of the cPLA2a
+/+ brain. A similar level of ACA
blood flow reduction was measured in the anterior
regions of the contralateral cortex of cPLA2a
-/- mice.
Therefore, differences in rCBF between the genotypes
Figure 2 cPLA2a is increased in the ischemic hemisphere following focal ischemia. A: A representative Western blot of cPLA2a
+/+ brain
protein fractions (25 μg each lane) from the non-ischemic (contralateral) and ischemic (ipsilateral) hemispheres. The same membrane was
exposed to antibody and developed sequentially for phospho-cPLA2a, cPLA2a, and actin. The panel on the left represents positive controls-
recombinant human cPLA2a (rh cPLA2a) and mouse spleen protein-and a negative control, cPLA2a
-/- brain protein. The antibody directed
against cPLA2a recognizes both the phosphorylated and nonphosphorylated cPLA2a. B, C: Densitometry analysis of Western blots for (B) total
cPLA2a (n = 5 experiments) and (C) phospho-cPLA2a (n = 5 experiments). * P < 0.05 ipsilateral compared to contralateral.
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intensity, COX-2, or neuronal loss in the cPLA2a
-/-
mice.
Activation of protein kinases, including p38 MAPK,
MEK1/2, and ERK1/2, has been implicated in neuronal
death and survival following cerebral reperfusion [30]
and has been associated with cPLA2a activity [7].
MCAO followed by 6 hour reperfusion caused increased
levels of phosphorylated p38 MAPK that were signifi-
cantly higher in the ischemic hemisphere of the cPLA2a
+/+ mice than in cPLA2a
-/- mice (Figure 7A). Phosphor-
ylation of MEK1/2 and ERK1/2 proteins was also signifi-
cantly greater in the ischemic hemispheres of cPLA2a
+/+
than cPLA2a
-/- mice (Figure 7B).
Discussion
The cPLA2a amplifies neural injury in animal models of
acute and chronic injury, and it is likely that it modu-
lates direct injury and inflammatory pathways [5,31,32].
In our previous study, we postulated that reduction of
infarct size in cPLA2a
-/- mice resulted from a reduction
in the delayed extension of injury into the penumbra
[5]. In the current study, we measured cPLA2a expres-
sion after I/R and compared COX-2 expression, PGE2
levels and ROS formation in the brains of cPLA2a
+/+
and cPLA2a
-/- mice at different times after reperfusion
(0-6 hours). Importantly, these early time points precede
the largest influx of circulating inflammatory cells and
blood-brain barrier disruption in experimental stroke
[7,33]. Our results show for the first time that ischemia
induces cPLA2a expression and this is correlated with
COX-2 expression and formation of ROS (as indicated
by HE intensity). Taken together, our results indicate
that cPLA2a plays an important role in vivo in the early
toxic events after I/R.
The changes in the levels of cPLA2a protein that we
observed following MCAO, while significant, were small.
The reasons for this include the fact that the abundance
of cPLA2a compared to other PLA2si nt h eb r a i ni s
small [34]. Secondly the proteins used for Western ana-
lysis are prepared from tissue samples that include
regions where cPLA2a levels may not have changed.
This will reduce the observed effect of ischemia on
cPLA2a expression. Previously published data support
the neuronal induction of cPLA2a following ischemia.
Alexandrov and colleagues [35] identified a hypoxia-sen-
sitive domain in the 5′-untranslated region of the
human cPLA2a gene that induces cPLA2a mRNA in
brain microvascular endothelial cells. Numerous studies
Figure 3 Neurons in the ischemic core of the cPLA2a
-/- mouse
are protected from injury. A: Neuronal swelling was measured by
threshold densitometry in brains from cPLA2a
+/+ and cPLA2a
-/-
mice after 2-hour MCAO, 2-hour MCAO and 2 hours of reperfusion,
or sham surgery; n = 3 mice/condition; * P < 0.01, unpaired t-test
comparing cPLA2a
+/+ to -/- at same condition. B: Nissl staining of
cPLA2a
+/+ and cPLA2a
-/- brains after 2-hour MCAO and 6 hours of
reperfusion. Vacuolated neurons (arrows) and nuclear condensation
(arrowheads) are seen in the ischemic core of cPLA2a
+/+ mice. Ipsi,
ipsilateral; Contra, contralateral; C, ischemic core; P, penumbra.
Table 1 cPLA2a
+/+ and -/- neuron size after MCAO, reperfusion or sham surgery
cPLA2a
+/+ Neuron Area (arbitrary units) cPLA2a
-/- Neuron Area (arbitrary units)
Ipsilateral Contralateral Ipsilateral Contralateral
Core Penumbra Core Penumbra Core Penumbra Core Penumbra
0 h Reperfuse 1.12 ± 0.21* 1.22 ± 0.30 * 0.55 ± 0.12 0.61 ± 0.15 0.68 ± 0.19 0.72 ± 0.12 0.46 ± 0.12 0.49 ± 0.08
2 h Reperfuse 0.91 ± 0.25 1.08 ± 0.28 * 0.62 ± 0.09 0.67 ± 0.18 0.83 ± 0.26 0.89 ± 0.21 0.53 ± 0.2 0.62 ± 0.11
Sham 0.52 ± 0.09 0.60 ± 0.09 0.47 ± 0.13 0.63 ± 0.11 0.40 ± 0.13 0.43 ± 0.09 0.44 ± 0.12 0.45 ± 0.09
Relative neuron size was determined in fluorescent Nissl-stained brain sections by threshold densitometry. Sections from the ipsilateral and contralateral
hemispheres were matched for position in mice that were subjected to 2 hours MCAO, MCAO and 2 hours reperfusion or sham surgery. The data are an index of
the average number of pixels in a neuron for each condition. * P < 0.01 for +/+ as compared to -/- of the same condition.
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mRNA expression in neurons [6], and a recent study
showed that cPLA2a is expressed in neurons in a mouse
model of Alzheimer’s disease [8]. After transient global
ischemia, late induction of cPLA2a was found only in
glial cells [37]. Other investigators have noted an early
increase in PLA2 activity minutes after global cerebral I/
R [38]. A rat model of transient cerebral ischemia
showed that cPLA2a activity increased 1 day after reper-
fusion but that the levels of protein and phospho-
cPLA2a did not increase until 3 days after reperfusion
[7]. Changes in cPLA2a that occur hours to days follow-
ing ischemia may be related to secondary injury and
inflammation.
In cell culture models, chemical anoxia [39] and
increased intracellular calcium [40] cause cPLA2a to
translocate to nuclear and other membranes. In our
immunofluorescence and subcellular fractionation
experiments ischemia did not cause translocation of
cPLA2a to membranes. There are several potential
explanations for the lack of cPLA2a membrane associa-
tion. In the gerbil global ischemia model, 5-LO did not
translocate to the nucleus until minutes after reperfu-
sion [17]. Similarly, reoxygenation following ischemia
appears to be a major determinant of intracellular Ca
2+
flux (reviewed by Szydlowska and Tymianski [41]).
Thus, it is possible that cPLA2a translocates to cellular
membranes minutes after reperfusion. Further experi-
ments examining the immediate reperfusion period will
be necessary to delineate the intracellular signalling
events of cPLA2a activation and translocation in
neurons.
How could cPLA2a impact neuronal injury at times
that precede classical neuroinflammation? Mechanisms
including increased PG synthesis and action, modulation
of excitotoxic responses and increased ROS stress have
been postulated.
The cPLA2a-associated increase in PGE2 levels in
cPLA2a
+/+ cortex following MCAO are consistent with
these postulates. In the ischemic core, we found that
Figure 4 cPLA2a regulates post-ischemic COX-2 levels. Immunofluorescence of COX-2 (green) and fluorescent Nissl dye (blue) in brain slices
from cPLA2a
+/+ and cPLA2a
-/- mice after 2-hour MCAO, 2-hour MCAO and 2-hour reperfusion, or sham surgery. Images of the ischemic core
and penumbra regions from the ipsilateral and contralateral hemispheres of each genotype are shown. Representative images, n = 3 mice of
each genotype. Ipsi, ipsilateral; Contra, contralateral.
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Page 8 of 13neuronal COX-2 induction was delayed and decreased
in the cPLA2a
-/- m i c ea n dt h a tc P L A 2a
-/- neuronal
architecture was preserved. Basal cerebral COX-2 activ-
ity and protein levels are significantly decreased in
cPLA2a
-/- mice [15], and we previously found that corti-
cal COX-2 and PGE2 responses to lipopolysaccharide
were attenuated in cPLA2a
-/- mice [10]. Systemic effects
of MCAO may explain the increase in PGE2 in both
hemispheres following unilateral MCAO. Work from
several laboratories indicates that PGE2 signalling
through the EP1 or EP3 receptors exacerbates early
stroke injury [22,42-44], perhaps through increased
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Figure 5 Concentration of cortical PGE2 following MCAO and reperfusion is dependent on cPLA2a.P G E 2 was measured in cortical
homogenate from the ipsilateral and contralateral hemispheres after A: 2 hours MCAO or sham operation and B: 2 hours of MCAO and 6 hours
reperfusion. Results are expressed as normalized for each lipid extraction and assay. * P < 0.05; ** P < 0.01 n = 3 - 4 each condition.
Kishimoto et al. Journal of Neuroinflammation 2010, 7:42
http://www.jneuroinflammation.com/content/7/1/42
Page 9 of 13Figure 6 Oxidative stress is greater in cPLA2a
+/+ than in cPLA2a
-/- mice after MCAO. A: ROS were measured in cPLA2a
+/+ and cPLA2a
-/-
mice that were injected with dihydroethidium (HE) immediately before MCAO or after sham surgery. The intensity of HE staining in brain
sections from the indicated time points was measured by densitometry. Ipsi, ipsilateral; Contra, contralateral; n = 3 mice/condition with 120-130
neurons counted/mouse; † P < 0.01. B: CBF was measured in mice by [
14C]-IAP autoradiography in the ACA and MCA territories of each cortex
at 60 minutes of MCAO. The left axis shows the position (in mm) of each region relative to bregma, and the right axis shows the absolute rCBF
(ml/100 g/min); 24 slices from n = 4 mice/group. * P < 0.01 and † P < 0.05 as compared to the same region in cPLA2a
+/+ mice.
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Page 10 of 13calcium responses [23]. Kunz and colleagues observed
that early morphologic changes in neurons represented
terminal injury and showed that such injury correlated
with COX-2 expression and was dependent on PGE2
and EP1 receptors but not on formation of ROS [20].
Indeed, Miettinen and co-authors used a nonspecific
PLA2 inhibitor to ameliorate both injury and COX-2
induction following transient MCAO and suggested that
neurons that express cPLA2a a r em o r es e n s i t i v et o
ischemic damage [28]. The coordinated neuronal activ-
ities of cPLA2a and COX-2 generate eicosanoids after
ischemia which are likely coupled to neuronal G-pro-
tein-coupled receptors in a toxic cascade.
Metabolism of AA results in the generation of super-
oxide, and a detailed kinetic analysis of brain lipids
showed decreased AA incorporation in phospholipids of
cPLA2a
-/- mouse brains [45]. Targeting cPLA2a to the
endoplasmic reticulum exacerbates oxidative stress in
cultured cells [46]. In the rat, transient global ischemia
causes a rapid release of free fatty acids from the cortex
that correlates with an increase in cPLA2a activity dur-
ing the period of ischemia [47]. It is likely that the
ischemic cortex of a cPLA2a
-/- mouse has less stimu-
lated AA release and therefore less ROS formation.
cPLA2a may contribute to ROS formation through an
AA-dependent, COX-2 independent pathway.
AA released by cPLA2a also has the potential to sig-
nificantly affect glutamate excitotoxicity. The application
of a cPLA2a inhibitor to cultured hippocampus signifi-
cantly protected pyramidal neurons from oxygen-glu-
cose deprivation [24], and PLA2 inhibitors reduced the
release of excitatory amino acids from the cortical sur-
face following 4-vessel occlusion in the rat [48]. In cul-
tured neurons, AA amplifies the calcium response to
NMDA stimulation [21]. Additionally, we reported that
cPLA2a activity causes increased neuronal death, rapid
broadening of action potentials, and increased Ca
2+
transients following NMDA exposure in the CA1 neu-
rons of acute hippocampal slices [19]. Therefore, it is
possible that I/R activates cPLA2a, causing excessive
release of AA, which amplifies the processes of
excitotoxicity.
The interaction between cPLA2a and the MAP kinase
pathways have potential importance in brain I/R injury.
Our data demonstrate that cPLA2a enhances ROS for-
mation by MCAO (Figure 7) while others have shown
that oxidative stress in mouse embryonic stem cells
causes MAPK dependent phosphorylation of cPLA2a
[49]. This interaction has the potential to form a posi-
tive feedback loop in which cPLA2a-dependent ROS
increase kinase activation which leads to further cPLA2a
activation. We examined the state of MAPK phosphory-
lation after 6 hours of reperfusion for several reasons.
First, our results demonstrated neuronal injury at this
time. Second, Alessandrini and colleagues [30] showed
that in vivo cerebral I/R activates these kinases and that
inhibition of MEKs is neuroprotective. Third, similar to
our results, 2 hours of MCAO followed by reperfusion
in the rat causes phosphorylation of ERK1/2 in both the
ipsilateral and contralateral cortex after 6 hours of
reperfusion [50]. Lastly, Nito et al. demonstrated that
p38 phosphorylation and activity peaked following
2 hours MCAO and 6 hours reperfusion [7]. A reduc-
tion in cPLA2a-dependent ROS may explain why p38
MAPK and MEK1/2-ERK1/2 proteins are less phos-
phorylated in the cPLA2a
-/- brain (Figure 7). Oxidative
stress activates p38 MAPK in neurons, which then acti-
vates caspases 8 and 9 and leads to neuronal apoptosis
[51]. Thus the interaction of cPLA2a with p38 MAPK
may amplify ischemic injury, as inhibition of p38 activity
in the rat decreases phosphorylation of cPLA2a and
attenuates stroke injury [7]. It is also possible that AA
released by cPLA2a can directly stimulate phosphoryla-
tion of p38 MAPK and ERK1/2 since this has been
demonstrated in cell lines [52]. Taken together this
pathway interaction may potentiate early neurologic
injury following MCAO.
Conclusions
The present findings demonstrate that cPLA2a is an
important modulator of the molecular events that occur
shortly after cerebral I/R. These events are likely to
amplify the cascade of inflammation, and cell death that
define the process of stroke progression. Our data
Table 2 Oxidative stress in cPLA2a
+/+ and -/- cortex after MCAO, MCAO and reperfusion, or sham surgery
cPLA2a
+/+ HE area (relative units) cPLA2a
-/- HE area (relative units)
Ipsilateral Contralateral Ipsilateral Contralateral
Core Penumbra Core Penumbra Core Penumbra Core Penumbra
0 h Reperfuse 45.02 ± 9.58† 38.36 ± 8.53† 6.99 ± 3.88 8.07 ± 4.70 12.76 ± 6.83 12.06 ± 5.85 4.66 ± 4.17 6.27 ± 3.83
2 h Reperfuse 33.01 ± 8.59† 30.70 ± 5.14† 8.82 ± 5.96 9.62 ± 5.95 20..09 ± 5.50 19.47 ± 6.72 6.60 ± 2.98 6.80 ± 4.09
Sham 6.32 ± 5.46 6.03 ± 5.03 5.63 ± 3.71 6.40 ± 4.65 4.11 ± 4.48 4.88 ± 5.43 3.85 ± 3.54 5.05 ± 5.67
Oxidative stress was measured in the cortex of cPLA2a
+/+ and -/- brains using micro-fluorescence and threshold densitometry. At the beginning of MCAO or
sham surgery 10 mg/kg dihydroethedium (HE) was injected into the relative jugular vein of each mouse. The intensity of HE staining in each region is normalized
for area and expressed in relative units. n = 3 mice per condition with analysis of high resolution confocal z-plane images from each mouse as described in the
text. †, P < 0.01 cPLA2a
+/+ compared to -/- at the same condition.
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Page 11 of 13suggest that the late administration of a cPLA2a inhibi-
tor may have limited efficacy in preventing neurologic
injury produced by I/R.
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